FDA inspection
Sciegen Pharmaceuticals Inc: FDA inspection ending Jun 21, 2019
FDA inspection 1093708 · Voluntary Action Indicated (VAI) · Hauppauge, NY
Key facts
| Inspection ID | 1093708 |
|---|---|
| Firm | Sciegen Pharmaceuticals Inc |
| FEI number | 3008298016 |
| Address | 89 Arkay Dr |
| City | Hauppauge |
| State | NY |
| ZIP | 11788 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | Jun 21, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data